These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1690997)

  • 1. The binding of endogenous and exogenous substance-P in human plasma.
    Corbally N; Powell D; Tipton KF
    Biochem Pharmacol; 1990 Apr; 39(7):1161-6. PubMed ID: 1690997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-binding of secretin in human plasma.
    Burhol PG; Jenssen TG; Florholmen J; Jorde R
    Acta Physiol Scand; 1985 Mar; 123(3):339-47. PubMed ID: 4061116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated concentrations of substance P and 5-HT in plasma in patients with carcinoid tumors.
    Emson PC; Gilbert RF; Martensson H; Nobin A
    Cancer; 1984 Aug; 54(4):715-8. PubMed ID: 6204735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in behaviour between synthetic and endogenous substance P in human plasma.
    Cannon DE; Skrabanek P; Powell D
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jul; 307(3):251-5. PubMed ID: 492346
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization and partial purification of a 5,700 dalton form of substance P-like immunoreactivity from the rat hypothalamus.
    Harmar AJ; Armstrong A; Lee CM; Emson PC
    Brain Res; 1984 Dec; 323(2):342-4. PubMed ID: 6084540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-induced internalization of the substance P (NK1) receptor expressed in epithelial cells.
    Garland AM; Grady EF; Payan DG; Vigna SR; Bunnett NW
    Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):177-86. PubMed ID: 7524481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of substance P in human plasma and in the rat circulation.
    Conlon JM; Göke B
    J Chromatogr; 1984 Jul; 296():241-7. PubMed ID: 6207188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
    Cascieri MA; Chicchi GG; Freidinger RM; Colton CD; Perlow DS; Williams B; Curtis NR; McKnight AT; Maguire JJ; Veber DF
    Mol Pharmacol; 1986 Jan; 29(1):34-8. PubMed ID: 2418347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flushing and plasma substance P concentration during infusion of synthetic substance P in normal man.
    Schaffalitzky De Muckadell OB; Aggestrup S; Stentoft P
    Scand J Gastroenterol; 1986 May; 21(4):498-502. PubMed ID: 2425412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoassay measurement of substance P release following a meat meal.
    Akande B; Reilly P; Modlin IM; Jaffe BM
    Surgery; 1981 Mar; 89(3):378-83. PubMed ID: 6162204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma substance P levels in fibrositis.
    Reynolds WJ; Chiu B; Inman RD
    J Rheumatol; 1988 Dec; 15(12):1802-3. PubMed ID: 2466119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of tachykinins by ileal and lung carcinoid tumors assessed by combined in situ hybridization, immunocytochemistry, and radioimmunoassay.
    Bishop AE; Hamid QA; Adams C; Bretherton-Watt D; Jones PM; Denny P; Stamp GW; Hurt RL; Grimelius L; Harmar AJ
    Cancer; 1989 Mar; 63(6):1129-37. PubMed ID: 2645037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of substance P-like immunoreactivity in plasma from man and dog.
    Nilsson G; Pernow B; Fischer GH; Folkers K
    Acta Physiol Scand; 1975 Aug; 94(4):542-4. PubMed ID: 1180093
    [No Abstract]   [Full Text] [Related]  

  • 14. A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative.
    Beaujouan JC; Torrens Y; Viger A; Glowinski J
    Mol Pharmacol; 1984 Sep; 26(2):248-54. PubMed ID: 6207421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the high molecular weight insulin-like growth factor complex in term pregnancy serum.
    Liu F; Baxter RC; Hintz RL
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1261-7. PubMed ID: 1385469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric chief cells possess NK1 receptors which mediate pepsinogen secretion and are regulated by agents that increase cAMP and phospholipase C.
    Kitsukawa Y; Turner RJ; Pradhan TK; Jensen RT
    Biochim Biophys Acta; 1996 Jun; 1312(2):105-16. PubMed ID: 8672532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of "purified" incubation damage by several radioimmunoassay separation methods.
    Tanaka K; Orth DN
    J Lab Clin Med; 1978 Jun; 91(6):881-92. PubMed ID: 650055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.
    Hirayama Y; Lei YH; Barnes PJ; Rogers DF
    Br J Pharmacol; 1993 Mar; 108(3):844-51. PubMed ID: 7682142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of excessive GnRH-binding substance on circulating maternal hCG in human pregnancy.
    Siler-Khodr TM; Smikle CB; Sorem KA; Grayson MA; Spencer DK; Yoder BA; Khodr GS
    Early Pregnancy; 1997 Mar; 3(1):10-4. PubMed ID: 9265553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoaffinity labeling the substance P receptor using a derivative of substance P containing p-benzoylphenylalanine.
    Boyd ND; White CF; Cerpa R; Kaiser ET; Leeman SE
    Biochemistry; 1991 Jan; 30(2):336-42. PubMed ID: 1703017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.